Actim Partus rapid test
Rule out preterm or imminent delivery
Actim Partus identifies the risk of preterm delivery through a simple cervical swab sample. The rapid test is based on highly specific monoclonal antibodies that bind to the phosphorylated form of insulin-like growth factor binding protein-1 (phIGFBP-1). phIGFBP-1 is produced in the decidua, but leaks into the cervix when the decidua and chorion detach.
Early identification of high-risk pregnancies allows timely treatment
Actim Partus is a simple and accurate rapid test to identify or rule out the risk of preterm delivery from week 22 until birth. The test can be used for all pregnant women, and it is reliable even in the presence of interfering substances.
Pros and facts
- Reliably rules out the risk of imminent or preterm delivery when fetal membranes are unbroken
- Test results are not affected by urine, semen, vaginal medications, bathing products or infections
- Easy-to-use one-step dipstick test
- The test kit contains all the materials needed to perform the test, and it can be stored at room temperature
Product is available in the following countries: